Physician profile

Eric A Duffield

Physician Assistant · Lansing, MI

NPI 1245427004

$4,589.86

in general payments reported to CMS, 2019-2025

42 companies · $931 in 2025

The $931 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,694.74

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boehringer Ingelheim Pharmaceuticals, INC. $1,032.78 2021-2025 Ofev, Stiolto Respimat, Spiriva Respimat
Glaxosmithkline, LLC. $689.26 2021-2025 Trelegy Ellipta, Arexvy
Abbvie INC. $398.21 2022-2025
Astrazeneca Pharmaceuticals LP $322.46 2021-2024 Breztri, Tezspire, Symbicort
Electromed, INC. $150.68 2021-2025 Smartvest
Janssen Biotech, INC. $144.25 2022-2025 Tremfya, Remicade, Simponi
Novo Nordisk INC $133.44 2022-2025 Rybelsus, Ozempic, Wegovy
Actelion Pharmaceuticals US, INC. $130.83 2021-2024 Opsumit
Grifols USA, LLC $129.58 2021-2025 Prolastin-C Liquid
3b Medical, INC. $128.06 2023 128.06
Philips North America LLC $99.18 2021-2023
Mylan Specialty L.P. $98.52 2021-2024 Yupelri
Pulmonx Corporation $97.51 2022-2024 Zephyr Delivery Catheter, Chartis Catheter, Zephyr Endobronchial Valve
Ucb, INC. $94.93 2025 Bimzelx
Harmony Biosciences LLC $93.20 2022-2023 Wakix
Show all 42 companies
CompanyGeneral paymentsYearsTop products
Takeda Pharmaceuticals U.S.A., INC. $69.98 2023-2025 Glassia
Amgen INC. $59.85 2021
Lilly USA, LLC $59.33 2022-2025 Zepbound, Mounjaro
Genzyme Corporation $58.12 2022-2025
Novartis Pharmaceuticals Corporation $54.01 2021-2022
Regeneron Healthcare Solutions, INC. $51.68 2021-2022
Baxter Healthcare $43.67 2024-2025 Hillrom - Vest System Model 105 Home Care
Exact Sciences Corporation $43.30 2024 Cologuard Collection Kit
Insmed, INC. $43.08 2025 Arikayce
Teva Pharmaceuticals USA, INC. $38.12 2021-2022
Merck Sharp & Dohme LLC $37.64 2023-2024 Capvaxive, Gardasil 9, Gardasil
Biogen, INC. $34.37 2021-2022
Tactile Systems Technology INC $21.25 2023 Flexitouch Plus, Entre Plus
Vertex Pharmaceuticals Incorporated $20.87 2025
Idorsia Pharmaceuticals US INC $20.61 2023 Quviviq
Convatec INC. $18.24 2025
Antares Pharma, INC. $17.43 2024 Xyosted
Axsome Therapeutics, INC. $17.14 2025 Auvelity
Amarin Pharma, INC. $17.04 2021
Sunovion Pharmaceuticals INC. $16.66 2021
Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) $16.30 2025 Caplyta
Pfizer INC. $16.08 2023
Jazz Pharmaceuticals INC. $15.98 2021
Horizon Therapeutics Plc $15.54 2022
Mallinckrodt Hospital Products INC. $14.36 2021
Covis Pharma Gmbh $13.23 2022
Phadia US INC. $13.09 2023 Immunocap

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Eric A Duffield

$4,589.86

in general payments reported 2019-2025

Years
2021-2025
Top company
Boehringer Ingelheim Pharmaceuticals, INC.
Context
The $931 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).

https://glasscript.com/doctor/10863249/eric-a-duffield

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.